M&A exit valuations strong in spite of spotty IPO market
'We've seen very, very healthy M&A [exit] valuations for fundamentally strong companies,' says Robert Ackerman, a partner at Allegis Capital, in this video interview with The Deal Pipeline.
'We've seen very, very healthy M&A [exit] valuations for fundamentally strong companies,' says Robert Ackerman, a partner at Allegis Capital, in this video interview with The Deal Pipeline.